TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership446,720 shares
Latest Disclosed Value $ 13,316,722
Barclays Plc ownership in 1TGTX / TG Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 446,720 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $11,813,510 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 458,225 shares of TG Therapeutics, Inc.. This represents a change in shares of -2.51% during the quarter. The current value of the position is $15,188,480 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 446,720 -11,505 -2.51 13,317 -19.56 0.0032
2026-03-31 2025-09-30 13F/A-3 TG THERAPEUTICS COM 88322Q108 458,225 -162,321 -26.16 16,553 -25.88 0.0036
2026-03-19 2025-09-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 347,057 -273,489 8,118 0.0022
2025-11-12 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 458,225 -162,321 16,553 0.0036
2026-02-27 2025-06-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 620,546 367,452 145.18 22,333 123.80 0.0051
2025-08-14 2025-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 620,546 367,452 22 0.0051
2025-08-13 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 620,546 367,452 22 0.0017
2026-03-17 2025-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 253,094 -64,469 -20.30 9,979 4.40 0.0028
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 253,094 -64,469 10 0.0028
2026-03-19 2024-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 317,563 -29,494 -8.50 9,559 17.75 0.0027
2025-02-13 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 317,563 -29,494 10 0.0027
2026-03-31 2024-09-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 347,057 207,723 149.08 8,118 227.56 0.0022
2024-11-19 2024-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 347,057 207,723 8 0.0022
2024-11-15 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 347,057 207,723 8 0.0007
2026-03-23 2024-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 139,334 -17,046 -10.90 2,479 4.21 0.0008
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 139,334 -17,046 2 0.0008
2026-03-24 2024-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 156,380 -271,633 -63.46 2,379 -67.47 0.0008
2024-05-15 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 156,380 -271,633 2 0.0008
2026-03-25 2023-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 428,013 -9,629 -2.20 7,310 99.84 0.0027
2024-02-15 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 428,013 -9,629 7 0.0027
2026-03-26 2023-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 437,642 -45,440 -9.41 3,659 -69.51 0.0023
2023-11-07 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 437,642 -45,440 4 0.0023
2026-03-30 2023-06-30 13F/A-2 TG THERAPEUTICS COM 88322Q108 483,082 -307,011 -38.86 12,000 0.98 0.0076
2023-09-20 2023-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 483,082 -307,011 12 0.0076
2023-08-03 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 483,082 -307,011 12 0.0076
2026-03-30 2023-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 790,093 274,125 53.13 11,883 94.69 0.0055
2023-05-04 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 790,093 274,125 12 0.0055
2026-03-30 2022-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 515,968 -76,161 -12.86 6,104 74.12 0.0027
2023-02-13 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 515,968 -76,161 6 0.0027
2022-11-03 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 592,129 262,360 79.56 3,505 150.18 0.0038
2022-08-12 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 329,769 189,478 135.06 1,401 5.02 0.0009
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 140,291 -78,104 -35.76 1,334 -67.86 0.0010
2022-02-23 2021-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 218,395 118,164 117.89 4,150 24.40 0.0015
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 218,395 118,164 4,150 0.0005
2021-11-09 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 100,231 75,588 306.73 3,336 248.95 0.0015
2021-08-13 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 24,643 -96,666 -79.69 956 -83.65 0.0005
2021-05-13 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 121,309 60,120 98.25 5,847 83.69 0.0031
2021-02-11 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 61,189 -420,827 -87.31 3,183 -75.32 0.0017
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 482,016 -441,933 -47.83 12,898 -28.34 0.0077
2020-08-12 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 923,949 63,030 7.32 17,998 112.47 0.0139
2020-05-13 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 860,919 67,497 8.51 8,471 -3.82 0.0067
2020-02-10 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 793,422 631,210 389.13 8,807 867.80 0.0049
2019-11-15 2019-09-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 162,212 96,449 146.66 910 59.93 0.0006
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 162,212 96,449 910 210.3930
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 65,763 47,722 264.52 569 292.41 0.0003
2019-05-15 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 18,041 -33,217 -64.80 145 -30.95 0.0001
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 51,258 26,377 106.01 210 50.00 0.0002
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 24,881 15,298 159.64 140 11.11 0.0001
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 9,583 -13,721 -58.88 126 -61.93 0.0001
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 23,304 12,053 107.13 331 255.91 0.0003
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 11,251 -14,670 -56.60 93 -69.71 0.0001
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 25,921 -28,156 -52.07 307 -43.46 0.0003
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 54,077 53,265 6,559.73 543 5,933.33 0.0006
2017-05-15 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 812 -1,301 -61.57 9 -10.00 0.0000
2017-02-14 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 2,113 1,183 127.20 10 25.00 0.0000
2016-11-14 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 930 889 2,168.29 8 0.0000
2016-08-12 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 41 -12,034 -99.66 0 -100.00
2016-05-16 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 12,075 11,894 6,571.27 97 4,750.00 0.0001
2016-02-12 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 181 -1,633 -90.02 2 -88.89 0.0000
2015-11-13 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 1,814 -4,606 -71.74 18 -82.52 0.0000
2015-08-14 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 6,420 554 9.44 103 18.39 0.0001
2015-05-19 2015-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 5,866 -177,685 -96.80 87 -96.84 0.0001
2015-05-14 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 5,866 87
2015-02-13 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 183,551 182,079 12,369.50 2,753 19,564.29 0.0026
2014-11-14 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 1,472 1,067 263.46 14 250.00 0.0000
2014-08-14 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 405 -277 -40.62 4 0.00 0.0000
2014-05-15 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 682 337 97.68 4 300.00 0.0000
2014-02-13 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 345 -236 -40.62 1 -66.67 0.0000
2013-11-14 2013-09-30 13F TG THERAPEUTICS COM 88322Q108 581 -89 -13.28 3 -25.00 0.0000
2013-08-14 2013-06-30 13F TG THERAPEUTICS COM 88322Q108 670 670 4 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-19 2024-09-30 13F/A TG THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A TG THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F TG THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A TG THERAPEUTICS OPT Call 49,400 879 n/a n/a n/a
2024-08-14 2024-06-30 13F TG THERAPEUTICS OPT Call 49,400 1 n/a n/a n/a
2026-03-30 2023-03-31 13F/A TG THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-04 2023-03-31 13F TG THERAPEUTICS OPT Call 0 0 n/a n/a n/a
2026-03-30 2022-12-31 13F/A TG THERAPEUTICS OPT Call 194,100 2,296 n/a n/a n/a
2023-02-13 2022-12-31 13F TG THERAPEUTICS OPT Call 194,100 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.